Location Turin, Piemonte, Italy Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Website www.nibbiotec.com/team/ LinkedIn View on LinkedIn
He has been the CEO of NIB Biotec since 2017, steering the company through significant growth and securing two major investments. With a Ph.D. in Molecular Medicine, he brings over 15 years of experience in both preclinical and clinical research. Sergio is also an inventor, author of several patents related to prostate cancer. His expertise
extends beyond the laboratory; he holds a Master’s degree in Communication Management and has completed a course in Social Entrepreneurship and Impact Investing. His diverse background has been pivotal in advancing NIB Biotec’s mission to innovate in the medtech industry.
